Insulin receptor tyrosine kinase activation, induced by insulin-stimulated autophosphorylation, was measured using a synthetic peptide containing residues 1142-1153 of the insulin receptor and shown to be reversed by both particulate and soluble phosphotyrosyl protein phosphatases from rat liver. Deactivation of the tyrosine kinase was highly sensitive to phosphatase action and was correlated best with disappearance of insulin receptors triphosphorylated in the tyrosine-1 150 domain. Dephosphorylation of the di-and mono-phosphorylated forms of the tyrosine-1150 domain generated during dephosphorylation or of phosphorylation sites in the C-terminal or putative juxtamembrane domains occurred 3-> 10-fold more slowly than deactivation of the tyrosine kinase, and these phosphorylated species did not appear to appreciably (< 20 %) contribute to tyrosine kinase activation. These results indicate that the transition from the triply to the doubly phosphorylated form of the tyrosine-1150 domain acts as an important switch for deactivation of the insulin receptor tyrosine kinase during dephosphorylation. The exquisite sensitivity of this dephosphorylation/deactivation event to phosphotyrosyl protein phosphatase action, combined with the high affinities of the phosphatases for substrates and the high activities of the phosphatases in cells, suggests that the tyrosine kinase activity expressed by insulin-stimulated insulin receptors is likely to be stringently regulated.
INTRODUCTION
The insulin receptor is a transmembranous heterotetrameric protein composed of two types of subunit linked by disulphide bonds to give a fl-a-a-fl structure (Rosen, 1987; Sale, 1988) . The a-subunit, which is entirely extracellular, contains the insulinbinding site, while the fl-subunit spans the membrane and possesses a tyrosine-specific protein kinase activity in a cytoplasmic domain. The tyrosine kinase is activated by insulin binding to the a-subunit. Mutant insulin receptors, in which lysine 1018 in the ATP-binding domain of the ,-subunit has been changed to one of several amino acids, which are expressed in cells, bind insulin normally but are totally inactive as kinases and are totally defective in mediating stimulation of metabolism by insulin (Ebina et al., 1987; Chou et al., 1987) . This suggests that the tyrosine kinase activity of the insulin receptor is critical for insulin signalling.
The tyrosine kinase catalyses autophosphorylation of the fisubunit. At least seven tyrosine residues in the fl-subunit have been reported to undergo autophosphorylation (Tornqvist et al., 1987 White et al., 1988; King & Sale, 1990) . These sites of autophosphorylation appear to be clustered in three domains. Two sites (tyrosine residues 1316 and 1322) are located in the Cterminal domain. Three sites (tyrosines 1146, 1150 and 1151) reside in the tyrosine-1150 domain. Two sites (tyrosines 953 and 960 or 972) are believed to reside in another domain which has putatively been identified as the juxtamembrane domain. All of these sites can be phosphorylated both in vivo and in vitro, although phosphorylation of the putative juxtamembrane domain sites has not always been observed. Insulin-stimulated autophosphorylation functions to dramatically increase insulin receptor tyrosine kinase activity towards other proteins (Rosen et al., 1983; Yu & Czech, 1984) . This is well illustrated with competing substrates which, when added prior to ATP and insulin, totally block insulin-stimulated autophosphorylation and as a consequence block insulin-stimulated substrate phosphorylation. Autophosphorylation maintains the tyrosine kinase in the activated state even in the absence of bound insulin. Thus dephosphorylation, and not simply dissociation of bound insulin, is required to terminate tyrosine kinase activity.
Analysis of the state of autophosphorylation of the ,-subunit and the ability of the tyrosine kinase to catalyse phosphorylation shows that activation of the tyrosine kinase of the rat and mouse insulin receptor correlates best with phosphorylation of all three tyrosines in the tyrosine-1 150 domain (White et al., 1988; FloresRiveros et al., 1989) . Thus the tyrosine-1 150 domain may function as a regulatory domain.
The majority (approx. 70 %) of phosphotyrosyl protein phosphatase activity against autophosphorylated insulin receptor appears to be located in the particulate fraction, at least in rat liver (King & Sale, 1988b) . Recently we have characterized the dephosphorylation of human insulin receptor autophosphorylation sites by both rat liver particulate and soluble phosphotyrosyl protein phosphatases (King & Sale, 1990) . Both phosphatase preparations behaved similarly and yielded marked differences in the rate of dephosphorylation of individual insulin receptor autophosphorylation sites, providing a good model system with which to analyse the role of the various autophosphorylation sites in tyrosine kinase activation. Moreover, the tyrosine-1150 domain of the insulin receptor in the triphosphorylated state was found to be exquisitely sensitive to dephosphorylation by the phosphatases (King & Sale, 1990) , and it was suggested that this may provide a sensitive mechanism for regulating insulin receptor tyrosine kinase action. To test this proposal further, the relationship between dephosphorylation of insulin receptor autophosphorylation sites and deactivation of the tyrosine kinase is examined in this study.
EXPERIMENTAL Materials
The peptide Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp-Tyr-Tyr-ArgLys, corresponding to amino acids 1142-1153 in the human insulin receptor precursor, was synthesized manually using a solid-phase method (Merrifield, 1986) . Other biochemicals and chemicals were obtained from sources described in King & Sale (1990) or .
Insulin receptor autophosphorylation, dephosphorylation and tyrosine kinase assay Insulin receptors were purified partially from solubilized human placental membranes by affinity chromatography on wheat-germ-agglutinin-agarose as previously described . The receptor was preincubated (approx. 1.5 mg of protein/ml) for 10 min at 22°C in 0.1-1 ml of a solution containing 50 mM-Hepes (pH 7.4), 4.8 mM-MnCl2, 180 nminsulin and 0.1 % Triton X-100 (Sale et al., 1986) King & Sale, 1988b) . For measurement of dephosphorylation, incubations with 32P-labelled insulin receptors were terminated by adding Laemmli (1970) sample buffer followed by boiling for 2 min, and samples were then subjected to SDS/PAGE and autoradiography (King & Sale, 1990 Under the assay conditions used, the contribution of epidermal growth factor receptor, which is also present, to peptide phosphorylation was estimated to be < 100% of that due to autophosphorylated insulin receptor. Control experiments established that the insulin receptor was not significantly phosphorylated on serine by liver extracts. This was not unexpected as there was no pretreatment, before preparation of extracts, with agents that activate the serine kinases. Tyrosine kinase assays were terminated after 10 min at 30°C by adding trichloroacetic acid to a concentration of 40% (w/v). After centrifugation (10 000 g, 5 min), 10 ,u portions were spotted on to Whatman P81 phosphocellulose paper and 32P incorporated into the peptide was determined as described previously (King & Sale, 1988 a). 32P incorporated into the peptide is expressed in terms of pmol/min for the 10 4u1 samples spotted onto the paper.
In the second protocol ( Fig. 3 ), insulin receptors were autophosphorylated with 250 /LM-[y-32P]ATP as above and then separated from [y-32P]ATP by rapid gel filtration at 4 'C (King & Sale, 1988b) . The autophosphorylated insulin receptor was incubated with 0.22 vol. of rat liver particulate or soluble fraction (5.5 mg/ml; final concentration I mg/ml). At the indicated times three samples were removed. One sample was mixed with Laemmli sample buffer, followed by boiling for 2 min, SDS/PAGE and autoradiography (King & Sale, 1990) . The /1-subunits were excised from the gels and analysed by peptide mapping. Duplicate samples were assayed for tyrosine kinase activity as above, except that the final [y-32P]ATP concentration was I mm. Although the concentration of insulin in these tyrosine kinase assays was likely to be low, the tyrosine kinase activity of insulin receptors activated by autophosphorylation is independent of the insulin concentration.
The Km of non-phosphorylated or phosphorylated insulin receptors for ATP was 10-25,UM, in agreement with previous studies (Kwok et al., 1986) . Thus ATP concentrations during autophosphorylation or tyrosine kinase assay were at least 10-fold greater than the Km of the receptor for ATP.
Preparation of particulate and soluble fractions Particulate and soluble fractions containing phosphotyrosyl protein phosphatase activity were prepared from a rat liver homogenate by centrifugation at 100000 g for I h as previously described (King & Sale, 1988b ) by using 50 mM-Hepes buffer (pH 7.4) containing I mM-dithiothreitol, 5 mM-EDTA, 0.5 mm-EGTA, I mM-benzamidine, I ,ug of leupeptin/ml, I jug of soyabean trypsin inhibitor/ml and a 1: 1000 dilution of 2.5 % (v/v) phenylmethanesulphonyl fluoride dissolved in propan-2-ol.
Peptide mapping
Digestions with trypsin (treated with Tos-Phe-CH2Cl) and two-dimensional tryptic peptide mapping on cellulose thin layer plates followed by autoradiography were performed as described previously (King & Sale, 1990 (d) Putative juxtamembrane domain (King & Sale, 1990) Phosphoamino acid analysis was performed as described by . Autoradiographs of peptide maps were quantified by scanning as previously described (King & Sale, 1990) . The total yield of phosphopeptides from the fl-subunit was calculated from the 32P in the f-subunit, determined by liquid scintillation counting as described in King & Sale (1990) , and from the ratio of 32P recovered in phosphopeptides. The amount (fmol) of each phosphorylated species was then calculated by dividing the amount of 32P (fmol) in the phosphopeptides by the number of sites phosphorylated. The numbering of insulin receptor amino acids used in this paper is based on the sequence of the precursor of the human insulin receptor described by Ullrich et al. (1985) .
RESULTS
The insulin receptor was autophosphorylated by incubation in the presence of 250 /M-ATP and insulin for 30 min at 22°C (King & Sale, 1990 active in the presence of EDTA (King & Sale, 1988b) . The distribution of 32P amongst autophosphorylation sites was determined by two-dimensional peptide mapping of tryptic phosphopeptides. The tyrosine kinase activity of the insulin receptor was assayed with the synthetic peptide containing residues 1142-1153 of the insulin receptor; this contains three of the tyrosine residues autophosphorylated in the insulin receptor (tyrosines 1 146, 1150 and 1 151). At concentrations in the 1-5 mm range this peptide also inhibits insulin receptor autophosphorylation and consequently reactivation of tyrosine kinase activity which may otherwise occur during the assay of tyrosine kinase activity (White et al., 1988; Wilden et al., 1990) .
Figs. I and 2 show the time courses of dephosphorylation of insulin receptor autophosphorylation sites and deactivation of the tyrosine kinase by rat liver preparations of soluble and particulate phosphotyrosyl protein phosphatase. As a control the tyrosine kinase activity of non-phosphorylated insulin receptors in the presence of insulin was also measured. Wilden et al. (1990) During the first 2 min of incubation with either phosphatase, the amounts of insulin receptor diphosphorylated in the tyrosine-1150 domain increased significantly, in the opposite direction to the change in tyrosine kinase activity (Figs. la, lc, 2a and 2c) . After a 2 min incubation with either phosphatase, approx. 40 % of insulin receptor fl-subunits appeared to be diphosphorylated in the tyrosine-1150 domain. Similarly, the amount of insulin receptors monophosphorylated in the tyrosine-1 150 domain increased during incubation with either phosphatase, reaching a peak after around 10 min of incubation, at which time approx. 5000 of insulin receptor fl-subunits appeared to contain this phosphorylated species (Figs. Ic and 2c) . Thus substantial amounts of the partially phosphorylated forms of the tyrosine-1150 domain persisted after the tyrosine kinase activity was largely deactivated. Additionally, as the di-and monophosphorylated forms of the tyrosine-1 150 domain and the putative monophosphorylated form of the juxtamembrane domain underwent net dephosphorylation in the latter stages of incubation, there was little change in tyrosine kinase activity (Figs. la, lc, ld, 2a, 2c and 2d) . Changes in the level of phosphorylation of the monophosphorylated form of the Cterminal domain did not correlate with deactivation (Figs. la, (Fig. 3) , and occurred faster than dephosphorylation of the other species (results not shown).
DISCUSSION
Results presented here indicate that conversion of the triphosphorylated tyrosine-1 150 domain species to its diphosphorylated derivative acts as an important switch for deactivation of the insulin receptor tyrosine kinase during dephosphorylation. This dephosphorylation/deactivation event was exquisitely sensitive to phosphatase action and occurred many-fold faster than dephosphorylation of other autophosphorylation sites. Thus substantial amounts of the partially phosphorylated forms of the tyrosine-1 150 domain and the receptor diphosphorylated in the C-terminal and putative juxtamembrane domains remained after the deactivation event was largely complete. Previously there had been no information on whether phosphorylation of the putative juxtamembrane domain could be activating, although its phosphorylation was reported to correlate with the extent of kinase activation . The key activating role of the triphosphorylated tyrosine-1150 domain species of the human insulin receptor found in this study during dephosphorylation supports correlations made between the tyrosine kinase activity of the rat and mouse insulin receptor and site occupancy during phosphorylation (White et al., 1988; Flores-Riveros et al., 1989) and the observation that proteolytic removal of the C-terminal domain does not affect the tyrosine kinase activity of the rat insulin receptor (Goren et al., 1987) . Evidence for a requirement of phosphorylation of all three tyrosines in the tyrosine-1150 domain for full activation of the tyrosine kinase is provided by studies with mutant insulin receptor molecules in which tyrosine residues 1146 or 1150 or 1150 and 1151 have been replaced by phenylalanine (Ellis et al., 1986; Wilden et al., 1990 tyrosine-1150 domain species generated by the action of the rat liver particulate or soluble phosphatases is known to be phosphorylated on tyrosines 1146 and 1150 or 1151 (King & Sale, 1990) , indicating that this species was deactivated. Additionally, this species has been trapped during phosphorylation by including anti-phosphotyrosine antibody and shown to have a tyrosine kinase activity comparable with that of the nonphosphorylated insulin receptor (White et al., 1988) . The remainder (15-20%) of the diphosphorylated tyrosine-1150 domain species present during dephosphorylation are known to be phosphorylated on both tyrosines 1150 and 1151 (King & Sale, 1990) , but because of their small proportion, it was not possible to ascertain from this study whether this species played a role in tyrosine kinase activation. Flores-Riveros et al. (1989) have, however, argued that the tyrosine kinase of mouse insulin receptor, which is diphosphorylated on the corresponding vicinal tyrosine residues 1152 and 1153, is not activated. In the study of Flores-Riveros et al. (1989) the appearance of the diphosphorylated tyrosine-1150 domain species, of which approx. 37.5% were phosphorylated on the vicinal tyrosines, and the appearance of the diphosphorylated C-terminal domain species preceded tyrosine kinase activation during phosphorylation.
Phosphotyrosyl protein phosphatases purified using various artificial phosphotyrosyl protein substrates have been shown to be specific for dephosphorylating phosphotyrosyl residues in artificial proteins, and showed little activity against phosphoseryl/phosphothreonyl proteins (Roome et al., 1988; Tonks et al., 1988a; Swarup & Subrahmanyam, 1989 (Roome et al., 1988; Tonks et al., 1988a; Swarup & Subrahmanyam, 1989) . The phosphotyrosyl protein phosphatases, therefore, exhibit a 20-50-fold higher affinity for protein substrates than do the serine/threonine phosphatases.
The particulate and soluble fractions containing phosphotyrosyl protein phosphatases used in this study will contain the native spectrum of phosphatases found' in vivo. The rapid dephosphorylation of the triphosphorylated tyrosine-1150 domain species and deactivation of tyrosine kinase activity by phosphotyrosyl protein phosphatases may offer a sensitive mechanism for terminating or regulating insulin receptor tyrosine kinase action and insulin signalling. Moreover, the phosphotyrosyl protein phosphatase activity in cells is high [e.g. 10000 units/g in the particulate fraction of human placenta with phosphotyrosyl lysozyme as substrate under Vm conditions, compared with levels of 2600 units/g and 1300 units/g for protein phosphatases 1 and 2A respectively in skeletal muscle (Tonks et al., 1988b) ], and the phosphotyrosyl protein phosphatases have very high affinities for model substrates (see above). Thus the tyrosine kinase activity expressed by insulin-stimulated receptors is likely to be under tight control. This is supported by the low levels of the triphosphorylated form of the tyrosine-1 150 domain found in insulin-stimulated Fao or H4 rat hepatoma cells (White et al., 1988; , and the low activation state of the tyrosine kinase of the insulin receptor isolated from the insulin-stimulated Fao cells. This work was supported by grants from the British Diabetic Association and the Wessex Medical School Trust. M. J. K. thanks the S.E.R.C. for a research studentship.
